Translocation of PKC by yessotoxin in an in vitro model of alzheimer's disease with improvement of tau and β-amyloid pathology

ACS Chemical Neuroscience

Volumn 4, Issue 7, 2013, Pages 1062-1070

  Alonso, Eva ^a   Vale, Carmen ^a   Vieytes, Mercedes R ^a   Botana, Luis M ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Alzheimer's disease; Marine toxin; protein kinase C; yessotoxin

Indexed keywords

AMYLOID BETA PROTEIN; GLYCOGEN SYNTHASE KINASE 3; PROTEIN KINASE C; TAU PROTEIN; YESSOTOXIN;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CELL; CELL DEATH; CONTROLLED STUDY; CYTOSOL; IN VITRO STUDY; LEARNING; MEMBRANE; MEMORY; MOUSE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEADY STATE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLYCOGEN SYNTHASE KINASE 3; INDOLES; MALEIMIDES; MICE; MICE, TRANSGENIC; OXOCINS; PROTEIN KINASE C; TAU PROTEINS;

EID: 84880352492     PISSN: None     EISSN: 19487193     Source Type: Journal    
DOI: 10.1021/cn400018y     Document Type: Article

References (54)

1. Satake, M., MacKenzie, L., and Yasumoto, T. (1997) Identification of Protoceratium reticulatum as the biogenetic origin of yessotoxin Nat. Toxins 5, 164-167
2. Paz, B., Riobo, P., Fernandez, M. L., Fraga, S., and Franco, J. M. (2004) Production and release of yessotoxins by the dinoflagellates Protoceratium reticulatum and Lingulodinium polyedrum in culture Toxicon 44, 251-258
3. Miles, C. O., Wilkins, A. L., Hawkes, A. D., Selwood, A. I., Jensen, D. J., Munday, R., Cooney, J. M., and Beuzenberg, V. (2005) Polyhydroxylated amide analogs of yessotoxin from Protoceratium reticulatum Toxicon 45, 61-71
4. Ogino, H., Kumagai, M., and Yasumoto, T. (1997) Toxicologic evaluation of yessotoxin Nat. Toxins 5, 255-259
5. Takai, A. (1988) Okadaic acid. Protein phosphatase inhibition and muscle contractile effects J. Muscle Res. Cell Motil. 9, 563-565
6. Martín López, A., Gallardo Rodriguez, J., Sanchez Mirón, A., F., G. C., and Molina Grima, E. (2011) Immunoregulatory potential of marine algal toxins yessotoxin and okadaic acid in mouse T lymphocyte cell line EL-4 Toxicol. Lett. 207, 167-172
7. Alkon, D. L., Epstein, H., Kuzirian, A., Bennett, M. C., and Nelson, T. J. (2005) Protein synthesis required for long-term memory is induced by PKC activation on days before associative learning Proc. Natl. Acad. Sci. U.S.A. 102, 16432-16437
8. Hama, H., Hara, C., Yamaguchi, K., and Miyawaki, A. (2004) PKC signaling mediates global enhancement of excitatory synaptogenesis in neurons triggered by local contact with astrocytes Neuron 41, 405-415
9. Rossi, M. A., Mash, D. C., and deToledo-Morrell, L. (2005) Spatial memory in aged rats is related to PKCgamma-dependent G-protein coupling of the M1 receptor Neurobiol. Aging 26, 53-68
10. Cole, G., Dobkins, K. R., Hansen, L. A., Terry, R. D., and Saitoh, T. (1988) Decreased levels of protein kinase C in Alzheimer brain Brain Res. 452, 165-174
11. Cordey, M., Gundimeda, U., Gopalakrishna, R., and Pike, C. J. (2003) Estrogen activates protein kinase C in neurons: role in neuroprotection J. Neurochem. 84, 1340-1348
12. Sun, M. K. and Alkon, D. L. (2010) Pharmacology of protein kinase C activators: cognition-enhancing and antidementic therapeutics Pharmacol. Ther. 127, 66-77
13. Etcheberrigaray, R., Tan, M., Dewachter, I., Kuiperi, C., Van der Auwera, I., Wera, S., Qiao, L., Bank, B., Nelson, T. J., Kozikowski, A. P., Van Leuven, F., and Alkon, D. L. (2004) Therapeutic effects of PKC activators in Alzheimer's disease transgenic mice Proc. Natl. Acad. Sci. U.S.A. 101, 11141-11146
14. Alfonso, A., de la Rosa, L., Vieytes, M. R., Yasumoto, T., and Botana, L. M. (2003) Yessotoxin, a novel phycotoxin, activates phosphodiesterase activity. Effect of yessotoxin on cAMP levels in human lymphocytes Biochem. Pharmacol. 65, 193-208
15. Campas, M., de la Iglesia, P., Fernandez-Tejedor, M., and Diogene, J. (2010) Colorimetric and electrochemical phosphodiesterase inhibition assays for yessotoxin detection: development and comparison with LC-MS/MS Anal. Bioanal. Chem. 396, 2321-2330
16. Dell'Ovo, V., Bandi, E., Coslovich, T., Florio, C., Sciancalepore, M., Decorti, G., Sosa, S., Lorenzon, P., Yasumoto, T., and Tubaro, A. (2008) In vitro effects of yessotoxin on a primary culture of rat cardiomyocytes Toxicol. Sci. 106, 392-399
17. Hunter, R. W., Mackintosh, C., and Hers, I. (2009) Protein kinase C-mediated phosphorylation and activation of PDE3A regulate cAMP levels in human platelets J. Biol. Chem. 284, 12339-12348
18. Michael, A. E. and Webley, G. E. (1991) Prostaglandin F2 alpha stimulates cAMP phosphodiesterase via protein kinase C in cultured human granulosa cells Mol. Cell. Endocrinol. 82, 207-214
19. Gong, B., Vitolo, O. V., Trinchese, F., Liu, S., Shelanski, M., and Arancio, O. (2004) Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment J. Clin. Invest. 114, 1624-1634
20. Vitolo, O. V., Sant'Angelo, A., Costanzo, V., Battaglia, F., Arancio, O., and Shelanski, M. (2002) Amyloid beta -peptide inhibition of the PKA/CREB pathway and long-term potentiation: reversibility by drugs that enhance cAMP signaling Proc. Natl. Acad. Sci. U.S.A. 99, 13217-13221
21. Frey, U., Huang, Y. Y., and Kandel, E. R. (1993) Effects of cAMP simulate a late stage of LTP in hippocampal CA1 neurons Science 260, 1661-1664
22. Bailey, C. H., Bartsch, D., and Kandel, E. R. (1996) Toward a molecular definition of long-term memory storage Proc. Natl. Acad. Sci. U.S.A. 93, 13445-13452
23. Korsnes, M. S. and Espenes, A. (2011) Yessotoxin as an apoptotic inducer Toxicon 57, 947-958
24. Korsnes, M. S., Espenes, A., Hetland, D. L., and Hermansen, L. C. (2011) Paraptosis-like cell death induced by yessotoxin Toxicol. In Vitro 25, 1764-1770
25. Dal Canto, M. C. and Gurney, M. E. (1994) Development of central nervous system pathology in a murine transgenic model of human amyotrophic lateral sclerosis Am. J. Pathol. 145, 1271-1279
26. Turmaine, M., Raza, A., Mahal, A., Mangiarini, L., Bates, G. P., and Davies, S. W. (2000) Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease Proc. Natl. Acad. Sci. U.S.A. 97, 8093-8097
27. Franchini, A., Marchesini, E., Poletti, R., and Ottaviani, E. (2004) Acute toxic effect of the algal yessotoxin on Purkinje cells from the cerebellum of Swiss CD1 mice Toxicon 43, 347-352
28. Perez-Gomez, A., Ferrero-Gutierrez, A., Novelli, A., Franco, J. M., Paz, B., and Fernandez-Sanchez, M. T. (2006) Potent neurotoxic action of the shellfish biotoxin yessotoxin on cultured cerebellar neurons Toxicol. Sci. 90, 168-177
29. Barad, M., Bourtchouladze, R., Winder, D. G., Golan, H., and Kandel, E. (1998) Rolipram, a type IV-specific phosphodiesterase inhibitor, facilitates the establishment of long-lasting long-term potentiation and improves memory Proc. Natl. Acad. Sci. U.S.A. 95, 15020-15025
30. Vale, C., Alonso, E., Rubiolo, J. A., Vieytes, M. R., LaFerla, F. M., Gimenez-Llort, L., and Botana, L. M. (2010) Profile for amyloid-beta and tau expression in primary cortical cultures from 3xTg-AD mice Cell. Mol. Neurobiol. 30, 577-590
31. Ferrer, I., Gomez-Isla, T., Puig, B., Freixes, M., Ribe, E., Dalfo, E., and Avila, J. (2005) Current advances on different kinases involved in tau phosphorylation, and implications in Alzheimer's disease and tauopathie Curr. Alzheimer Res. 2, 3-18
32. Phiel, C. J., Wilson, C. A., Lee, V. M., and Klein, P. S. (2003) GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptide Nature 423, 435-439
33. Young, K. F., Pasternak, S. H., and Rylett, R. J. (2009) Oligomeric aggregates of amyloid beta peptide 1-42 activate ERK/MAPK in SH-SY5Y cells via the alpha7 nicotinic receptor Neurochem. Int. 55, 796-801
34. Fang, X., Yu, S., Tanyi, J. L., Lu, Y., Woodgett, J. R., and Mills, G. B. (2002) Convergence of multiple signaling cascades at glycogen synthase kinase 3: Edg receptor-mediated phosphorylation and inactivation by lysophosphatidic acid through a protein kinase C-dependent intracellular pathway Mol. Cell. Biol. 22, 2099-2110
35. Lavoie, L., Band, C. J., Kong, M., Bergeron, J. J., and Posner, B. I. (1999) Regulation of glycogen synthase in rat hepatocytes. Evidence for multiple signaling pathways J. Biol. Chem. 274, 28279-28285
36. Cho, J. H. and Johnson, G. V. (2004) Glycogen synthase kinase 3 beta induces caspase-cleaved tau aggregation in situ J. Biol. Chem. 279, 54716-54723
37. Bianchi, C., Fato, R., Angelin, A., Trombetti, F., Ventrella, V., Borgatti, A. R., Fattorusso, E., Ciminiello, P., Bernardi, P., Lenaz, G., and Parenti Castelli, G. (2004) Yessotoxin, a shellfish biotoxin, is a potent inducer of the permeability transition in isolated mitochondria and intact cells Biochim. Biophys. Acta 1656, 139-147
38. Korsnes, M. S., Hetland, D. L., Espenes, A., and Aune, T. (2006) Induction of apoptosis by YTX in myoblast cell lines via mitochondrial signalling transduction pathway Toxicol. In Vitro 20, 1419-1426
39. Reddy, P. H. and Beal, M. F. (2008) Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease Trends Mol. Med. 14, 45-53
40. Caspersen, C., Wang, N., Yao, J., Sosunov, A., Chen, X., Lustbader, J. W., Xu, H. W., Stern, D., McKhann, G., and Yan, S. D. (2005) Mitochondrial Abeta: a potential focal point for neuronal metabolic dysfunction in Alzheimer's diseas FASEB J. 19, 2040-2041
41. Hansson Petersen, C. A., Alikhani, N., Behbahani, H., Wiehager, B., Pavlov, P. F., Alafuzoff, I., Leinonen, V., Ito, A., Winblad, B., Glaser, E., and Ankarcrona, M. (2008) The amyloid beta-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae Proc. Natl. Acad. Sci. U.S.A. 105, 13145-13150
42. Marin, R., Ramirez, C. M., Gonzalez, M., Gonzalez-Munoz, E., Zorzano, A., Camps, M., Alonso, R., and Diaz, M. (2007) Voltage-dependent anion channel (VDAC) participates in amyloid beta-induced toxicity and interacts with plasma membrane estrogen receptor alpha in septal and hippocampal neurons Mol. Membr. Biol. 24, 148-160
43. Ferrer, I. (2009) Altered mitochondria, energy metabolism, voltage-dependent anion channel, and lipid rafts converge to exhaust neurons in Alzheimer's disease J. Bioenerg Biomembr. 41, 425-431
44. Chou, J. L., Shenoy, D. V., Thomas, N., Choudhary, P. K., Laferla, F. M., Goodman, S. R., and Breen, G. A. (2011) Early dysregulation of the mitochondrial proteome in a mouse model of Alzheimer's disease J. Proteomics 74, 466-479
45. Bredesen, D. E., Rao, R. V., and Mehlen, P. (2006) Cell death in the nervous system Nature 443, 796-802
46. Wei, L., Xiao, A. Y., Jin, C., Yang, A., Lu, Z. Y., and Yu, S. P. (2004) Effects of chloride and potassium channel blockers on apoptotic cell shrinkage and apoptosis in cortical neurons Pflugers Arch. 448, 325-334
47. Himi, T., Ishizaki, Y., and Murota, S. I. (2002) 4,4′- diisothiocyano-2, 2′-stilbenedisulfonate protects cultured cerebellar granule neurons from death Life Sci. 70, 1235-1249
48. Pei, J. J., Braak, E., Braak, H., Grundke-Iqbal, I., Iqbal, K., Winblad, B., and Cowburn, R. F. (1999) Distribution of active glycogen synthase kinase 3beta (GSK-3beta) in brains staged for Alzheimer disease neurofibrillary changes J. Neuropathol. Exp. Neurol. 58, 1010-1019
49. Sul, D., Kim, H. S., Lee, D., Joo, S. S., Hwang, K. W., and Park, S. Y. (2009) Protective effect of caffeic acid against beta-amyloid-induced neurotoxicity by the inhibition of calcium influx and tau phosphorylation Life Sci. 84, 257-262
50. Takashima, A., Yokota, T., Maeda, Y., and Itoh, S. (1991) Pretreatment with caerulein protects against memory impairment induced by protein kinase C inhibitors in the rat Peptides 12, 699-703
51. Alonso, E., Vale, C., Vieytes, M. R., Laferla, F. M., Gimenez-Llort, L., and Botana, L. M. (2011) 13-Desmethyl spirolide-C is neuroprotective and reduces intracellular Abeta and hyperphosphorylated tau in vitro Neurochem. Int. 59, 1056-1065
52. Alonso, E., Vale, C., Vieytes, M. R., Laferla, F. M., Gimenez-Llort, L., and Botana, L. M. (2011) The cholinergic antagonist gymnodimine improves Abeta and tau neuropathology in an in vitro model of Alzheimer disease Cell. Physiol. Biochem. 27, 783-794
53. Vale, C., Nicolaou, K. C., Frederick, M. O., Gomez-Limia, B., Alfonso, A., Vieytes, M. R., and Botana, L. M. (2007) Effects of azaspiracid-1, a potent cytotoxic agent, on primary neuronal cultures. A structure-activity relationship study J. Med. Chem. 50, 356-363
54. Varming, T., Drejer, J., Frandsen, A., and Schousboe, A. (1996) Characterization of a chemical anoxia model in cerebellar granule neurons using sodium azide: protection by nifedipine and MK-801 J. Neurosci. Res. 44, 40-46-46